aDepartment of Internal Medicine, Maastricht University Medical Centre +
bCARIM School for Cardiovascular Diseases, Maastricht University
cHeart and Vascular Centre
dDepartment of Radiology
eDepartment of Cardiology, Maastricht University Medical Centre +
fCAPHRI School for Public Health and Primary Care
gDepartment of Epidemiology, Maastricht University
hDepartment of Biomedical Engineering, Maastricht University Medical Centre +, Maastricht, The Netherlands
Correspondence to Koen D. Reesink, PhD, Department of Biomedical Engineering; CARIM School for Cardiovascular Diseases, Maastricht University, Universiteitssingel 50 (room H3.360), 6229 ER Maastricht, The Netherlands. Tel: +31 43 388 1659; e-mail: [email protected]
Abbreviations: ρ, blood density; δPWV, systolic–diastolic difference in carotid pulse wave velocity; AGE, advanced glycation endproduct; CEL, Nε-(carboxyethyl)lysine; cfPWV, carotid-to-femoral pulse wave velocity; CML, Nε-(carboxymethyl)lysine; cPWV, carotid pulse wave velocity; CVD, cardiovascular disease; D, diameter; DC, distensibility coefficient; DBP, diastolic blood pressure; eGFR, estimated glomerular filtration rate; HOMA2-IR, homeostasis model assessment 2 for insulin resistance; HR, heart rate; IMT, intima–media thickness; MAP, mean arterial pressure; NGM, normal glucose metabolism; PPcar, local carotid pulse pressure; RAS-inhibitor, renin–angiotensin system inhibitor; SAF, skin autofluorescence; SBP, systolic blood pressure; T2D, type 2 diabetes; ΔD, distension
Received 22 August, 2016
Revised 13 December, 2016
Accepted 18 January, 2017
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Website (http://www.jhypertension.com).